Tops & Flops Stocks
Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
---|---|---|---|---|---|---|---|
Viking Therapeutics Inc | 0.700% | 17.685% | -1.809% | 810.875% | 340.721% | 1350.678% | - |
Cymabay Therapeutics Inc | 0.670% | 0.671% | 0.671% | 282.166% | 36.364% | 685.340% | - |
Eli Lilly Corp. | 1.320% | 1.625% | 1.914% | 131.935% | 36.174% | 358.371% | 526.307% |
Catalyst Pharmaceutical Partners Inc | 0.170% | -2.873% | 13.719% | -1.228% | -3.185% | 304.599% | 222.854% |
Alpine Immune Sciences Inc | -1.730% | -3.261% | 7.229% | 384.683% | 98.883% | 278.723% | 337.777% |
Cytokinetics Inc. | -2.990% | 8.065% | -10.667% | 109.375% | -12.418% | 228.431% | - |
Mediwound Ltd. | 0.740% | -4.225% | 7.087% | 25.926% | 51.111% | 225.359% | 205.618% |
Savara Inc. | -1.350% | -0.889% | -7.469% | 137.171% | 4.206% | 220.863% | -29.430% |
Medpace Holdings Inc | 0.130% | 1.915% | 0.134% | 120.414% | 32.562% | 164.184% | - |
Madrigal Pharmaceuticals inc. | 1.580% | 1.181% | 8.507% | 9.000% | 13.434% | 147.778% | 101.988% |
Intra-Cellular Therapies Inc. | -0.470% | 4.207% | -4.309% | 52.210% | -1.227% | 138.166% | 512.750% |
Geron Corp. | -0.790% | -3.234% | 60.294% | 40.451% | 55.081% | 125.640% | 109.041% |
EyePoint Pharmaceuticals Inc. | 1.000% | -10.748% | -27.652% | 629.008% | -10.748% | 122.093% | - |
Regeneron Pharmaceuticals Inc. | -0.060% | 0.962% | -2.619% | 17.496% | 11.912% | 120.807% | 150.794% |
Voyager Therapeutics Inc | -1.080% | -6.878% | 6.667% | 29.450% | 10.692% | 114.634% | - |
Vertex Pharmaceuticals Inc. | 0.530% | 2.173% | -3.006% | 34.973% | 3.740% | 112.776% | 132.637% |
Celldex Therapeutics | 2.630% | -1.531% | -18.220% | 13.529% | 6.630% | 92.040% | 626.930% |
Sarepta Therapeutics | 1.140% | 4.113% | -7.819% | -0.915% | 35.906% | 89.759% | 15.703% |
Merck & Co. Inc. | 0.160% | 7.407% | 2.353% | 22.906% | 23.655% | 85.671% | 66.462% |
AbbVie Inc. | 0.840% | 3.158% | 0.909% | 14.172% | 18.915% | 85.441% | 134.648% |